A US Bankruptcy Court gave its approval to Savient Pharmaceuticals to sell all substantially all its assets to Crealta Pharmaceuticals, a firm backed by private equity company GTCR.
Crealta Pharmaceuticals
Breaking News
Private equity firm GTCR announced the partnership it formed with Ed Fiorentino for the formation of Crealta Pharmaceuticals Inc.
Subscribe to VCpost newsletter
Most Popular
- 940,000 Taxpayers May Receive Extra $932 Tax Refunds From IRS; Here's Why!
- Where's My Child Tax Credit 2024: When to Receive My Money After April 15 Tax Filing Deadline?
- SSDI Payment April 2024: Who Will Receive Social Security Benefits Today?
- In the Era of Shrinkflation, Cinemark Sued for Allegedly Swindling Customers by Shortchanging Them on Beverages
- SSI Payment for May 2024: Supplemental Security Income Recipients to See Double Amount in Payout
- Philippines Wants US, Japan to Fund Freight Railway Project After It Drops Funding Talks With China
- Convicted Fraudster Accused of Killing Wealthy Heiress Wife in Swimming Pool to Cash in on Over $4 Million Fortune
- Trump's $175 Million Fraud Bond is not Properly Backed, According to New York AG
